How to Use BPC-157 10mg: The Complete Reconstitution, Dosing and Injection Guide for UK Bodybuilders
BPC-157 10mg is the most commonly purchased peptide vial in UK bodybuilding, and most users receive it with no instructions beyond a label. You are left with a tiny pile of white powder, a vial of bacteriostatic water and a collection of conflicting forum posts telling you different reconstitution volumes, different doses and different injection protocols. This guide eliminates every question. Intex Pharma BPC-157 10mg is supplied as a lyophilised powder in a glass vial, and by the end of this guide you will know exactly how to reconstitute it, what dose to inject for your specific goal, where to inject it, how to store it and what to expect week by week.
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a naturally occurring protective protein in human gastric juice. It has been studied extensively in preclinical models for its effects on tendon, ligament, muscle, gut and blood vessel repair, primarily through upregulation of vascular endothelial growth factor (VEGF), nitric oxide modulation and growth hormone receptor expression at the tissue level. The research is covered in depth in the BPC-157 tendon recovery guide and the BPC-157 gut health guide for bodybuilders. This guide focuses entirely on the practical side: how to handle, prepare and administer BPC-157 10mg correctly.
What You Need Before You Start
Before opening your BPC-157 10mg vial, gather everything you need. Missing one item means interrupting the reconstitution process, which increases contamination risk.
BPC-157 10mg: Required Supplies Checklist
| Item | Specification | Why It Matters |
|---|---|---|
| Intex Pharma BPC-157 10mg vial | Lyophilised powder, Janoshik verified | Third-party tested for identity and purity. COA available in product gallery |
| Bacteriostatic water (BAC water) | 0.9% benzyl alcohol preserved; 10ml or 30ml vial | The benzyl alcohol prevents bacterial growth in the multi-dose vial. Do not use plain sterile water (no preservative, shorter usable life) or tap water |
| Sterile syringe for reconstitution | 1ml or 3ml syringe with 18 to 22 gauge needle | Used only for drawing bacteriostatic water and injecting it into the vial. Never inject yourself with this needle |
| Insulin syringes for injection | U-100, 1ml, 29 to 31 gauge, 8mm (5/16″) or 12.7mm (1/2″) needle | Used for daily dose administration. 100 units = 1ml. Each unit marking on the syringe corresponds to a calculable dose based on your reconstitution volume |
| Alcohol swabs | 70% isopropyl alcohol, individually wrapped | Swab the vial stopper before every draw and the injection site before every injection. Allow to dry fully before piercing |
| Sharps bin | Any approved sharps container | Dispose of every needle immediately after use. Never recap used needles |
How to Reconstitute BPC-157 10mg: Step by Step
Reconstitution is the process of dissolving the lyophilised BPC-157 10mg powder in bacteriostatic water to create an injectable solution. The process takes approximately two minutes and requires no special equipment beyond what is listed above. Handle the vial gently throughout: BPC-157 is a peptide, and while it is unusually stable compared to most peptides, aggressive shaking can denature the amino acid chain and reduce potency.
Step 1: Prepare your workspace. Wash your hands thoroughly with soap and water. Lay out all supplies on a clean surface. Remove the plastic flip-top cap from the BPC-157 10mg vial to expose the rubber stopper. Do not remove the metal crimp ring; it stays on the vial permanently.
Step 2: Swab both vials. Wipe the rubber stopper of the BPC-157 10mg vial with an alcohol swab. Wipe the rubber stopper of the bacteriostatic water vial with a separate alcohol swab. Allow both to air dry for 15 to 30 seconds. Do not blow on them.
Step 3: Draw the bacteriostatic water. Using the sterile reconstitution syringe (18 to 22 gauge), draw air into the syringe equal to the volume of water you intend to add (see the reconstitution volume table below). Insert the needle through the bacteriostatic water vial stopper, inject the air (this equalises pressure and makes drawing easier), then invert the vial and draw the desired volume of water into the syringe. Remove any large air bubbles by tapping the syringe barrel and pushing them back into the vial.
Step 4: Add the water to the BPC-157 10mg vial. Insert the needle through the BPC-157 vial stopper at a slight angle, aiming the tip of the needle towards the glass wall rather than directly onto the powder cake. Inject the water slowly, allowing it to run down the inside wall of the vial. Do not spray the water directly onto the powder, as this can create foam and potentially damage the peptide.
Step 5: Mix gently. Remove the needle. Gently swirl or roll the vial between your palms until the powder is fully dissolved. Do not shake vigorously. The resulting solution should be clear and colourless. If it is cloudy, contains particles or has an unusual colour, do not use it.
Step 6: Label and store. Write the date of reconstitution on the vial or on a piece of tape attached to it. Store the reconstituted BPC-157 10mg vial in the refrigerator at 2 to 8°C. Use within 28 days of reconstitution.
BPC-157 10mg Reconstitution Volumes: Which to Choose
The amount of bacteriostatic water you add to the BPC-157 10mg vial determines the concentration of the solution, which in turn determines how many units you draw on your insulin syringe for each dose. There is no single “correct” volume: it depends on your target dose and your preference for injection volume. The table below shows the three most common reconstitution options for a BPC-157 10mg vial, with syringe unit calculations for every standard dose.
BPC-157 10mg Reconstitution and Dosing Reference (U-100 Insulin Syringe)
| BAC Water Added | Concentration | 250mcg Dose | 500mcg Dose | 750mcg Dose | Total Doses per Vial (at 250mcg) |
|---|---|---|---|---|---|
| 2ml | 5,000mcg/ml (5mg/ml) | 5 units | 10 units | 15 units | 40 doses |
| 3ml | 3,333mcg/ml (3.33mg/ml) | 7.5 units | 15 units | 22.5 units | 40 doses |
| 4ml | 2,500mcg/ml (2.5mg/ml) | 10 units | 20 units | 30 units | 40 doses |
2ml reconstitution produces the highest concentration (5mg/ml), which means the smallest injection volumes. At 250mcg per dose, you draw only 5 units on the insulin syringe. The advantage is minimal injection volume and less subcutaneous fluid. The disadvantage is that 5 units is a very small volume to measure accurately on a standard U-100 syringe, and small measurement errors represent a larger percentage of the total dose. This option is best for experienced users comfortable with precise syringe handling.
3ml reconstitution is the middle ground and the most commonly recommended option for BPC-157 10mg vials. At 250mcg per dose, you draw 7.5 units. The measurement is more forgiving than 5 units while keeping injection volumes small. This is the option most UK bodybuilders use.
4ml reconstitution produces the most dilute solution (2.5mg/ml), which means the largest injection volumes but the easiest measurements. At 250mcg per dose, you draw 10 units, which is a clean, easy-to-read marking on any insulin syringe. This option is best for first-time peptide users who want the simplest possible dosing without worrying about measurement accuracy.
BPC-157 10mg Dosing by Goal
The correct dose of BPC-157 10mg depends on what you are using it for. Injury recovery, preventative connective tissue maintenance and gut health each have different dosing conventions based on the preclinical research and community-established protocols. No validated human clinical dose exists yet (a Phase 2 clinical trial for BPC-157 in hamstring injuries is currently underway), so the doses below are extrapolated from animal model data and represent the most widely used protocols in UK bodybuilding.
BPC-157 10mg Dosing Protocols by Goal
| Goal | Daily Dose | Frequency | Cycle Length | Injection Route | Vials Needed (10mg) |
|---|---|---|---|---|---|
| Active injury recovery | 500 to 750mcg | Once daily or split into 250mcg AM + 250 to 500mcg PM | 4 to 8 weeks | Subcutaneous, as close to injury site as possible | 1 to 2 vials |
| Moderate injury or chronic tendinopathy | 250 to 500mcg | Once daily | 6 to 12 weeks | Subcutaneous near injury site | 1 to 2 vials |
| Preventative connective tissue support (on cycle) | 250mcg | Once daily | Duration of steroid cycle | Subcutaneous, any site (abdomen, thigh) | 1 vial per 40 days |
| Gut healing (oral steroid damage, IBS, leaky gut) | 250 to 500mcg | Once daily, on an empty stomach | 4 to 8 weeks | Oral (dissolved in water) or subcutaneous abdominal | 1 to 2 vials |
| Post-surgical recovery support | 500mcg | Once or twice daily | 4 to 8 weeks post-surgery (after wound closure) | Subcutaneous near surgical site (once healed enough for injection) | 1 to 2 vials |
At 250mcg once daily, a single BPC-157 10mg vial provides 40 doses, which covers 40 days (nearly six weeks) of daily use. Dosing at 500mcg daily, one vial lasts 20 days. The higher recovery dose of 250mcg twice daily also provides 20 days of use from a single vial. For a full 8-week acute injury recovery protocol at 500mcg daily, plan on two vials of BPC-157 10mg. At £40.00 per vial from Intex Pharma, the total cost for a comprehensive 8-week recovery protocol is £80.00.
Local vs Systemic Injection: Where to Pin BPC-157 10mg
BPC-157 produces both local and systemic effects, but research consistently demonstrates enhanced healing velocity when injected as close to the injury site as anatomically feasible. The mechanism is concentration-dependent: BPC-157 drives angiogenesis (new blood vessel formation) most strongly at the point of highest concentration, which is the injection site itself. As the peptide diffuses outward through interstitial fluid, the concentration drops and the local angiogenic signal weakens.
BPC-157 10mg: Local vs Systemic Injection Guide
| Scenario | Injection Approach | Injection Site | Why |
|---|---|---|---|
| Accessible injury (shoulder, elbow, knee, Achilles) | Local subcutaneous | Within 1 to 3cm of the injured structure, into the subcutaneous tissue overlying it | Maximum peptide concentration at the healing site; strongest angiogenic signal |
| Deep injury (hip socket, spinal disc) | Systemic subcutaneous | Abdominal subcutaneous fat (standard peptide injection site) | Local injection is anatomically impractical; systemic delivery reaches the target via circulation |
| Gut healing (IBS, oral steroid GI damage, leaky gut) | Oral or abdominal subcutaneous | Oral: dissolve dose in 30ml water, drink on empty stomach. SubQ: lower abdominal injection | Oral puts BPC-157 directly in contact with GI mucosa. BPC-157 is unusually acid-stable for a peptide |
| General preventative support on cycle | Systemic subcutaneous | Abdomen, thigh or upper arm; rotate sites | Systemic distribution provides broad connective tissue support without targeting a specific injury |
| Muscle tear or strain | Local subcutaneous or intramuscular | SubQ over the affected muscle belly; IM into the muscle near the tear (only if comfortable with IM technique) | Direct delivery to the damaged muscle tissue accelerates repair |
Critical rule: never inject directly into a tendon. Tendons have poor blood supply and limited tolerance for direct injection. Always inject into the subcutaneous tissue overlying the tendon, within 1 to 3cm of the injured structure. The BPC-157 will diffuse through the interstitial fluid to reach the tendon beneath. For a detailed breakdown of injection sites mapped to specific bodybuilding injuries, see the BPC-157 tendon recovery guide.
How to Inject BPC-157 10mg: Subcutaneous Technique
Step 1: Wash your hands. Swab the BPC-157 10mg vial stopper with an alcohol wipe. Allow to dry.
Step 2: Draw a small amount of air into the insulin syringe (equal to your dose volume). Insert the needle through the vial stopper and inject the air into the vial. This equalises pressure and makes drawing the solution easier.
Step 3: Invert the vial. Slowly draw the required number of units for your dose. If air bubbles appear in the syringe barrel, tap the side gently with your fingernail to move them to the top, then push them back into the vial.
Step 4: Swab the injection site with a fresh alcohol wipe. Allow to dry completely (injecting through wet alcohol causes stinging).
Step 5: Pinch a fold of skin at the injection site. Insert the needle at a 45-degree angle into the subcutaneous tissue. If you cannot pinch at least 1cm of skin, reduce the angle to 30 degrees or choose a site with more subcutaneous fat.
Step 6: Inject slowly and steadily over 5 to 10 seconds. Rushing increases discomfort and can cause the solution to leak back out of the injection site.
Step 7: Withdraw the needle. Maintain the skin pinch for 10 seconds after withdrawal. Apply light pressure with the alcohol swab if there is any bleeding. Dispose of the needle immediately into your sharps bin.
Storage of BPC-157 10mg
BPC-157 10mg Storage Guidelines
| State | Temperature | Shelf Life | Notes |
|---|---|---|---|
| Lyophilised (unreconstituted) | Refrigerator (2 to 8°C) preferred; freezer (−20°C) for long-term storage | 12+ months in freezer; 6+ months refrigerated | Protect from light and moisture. Room temperature for short periods (shipping) is acceptable |
| Reconstituted (with BAC water) | Refrigerator (2 to 8°C) only | 28 days maximum | Do not freeze reconstituted solution. Do not leave at room temperature for extended periods. Swab stopper before every draw |
BPC-157 10mg Cost Per Week at Different Doses
Intex Pharma BPC-157 10mg: Cost Analysis by Dosing Protocol
| Daily Dose | Days per Vial | Cost per Day | Cost per Week | 8-Week Protocol Cost |
|---|---|---|---|---|
| 250mcg once daily | 40 days | £1.00 | £7.00 | £56.00 (1.4 vials) |
| 500mcg once daily | 20 days | £2.00 | £14.00 | £112.00 (2.8 vials) |
| 250mcg twice daily (500mcg total) | 20 days | £2.00 | £14.00 | £112.00 (2.8 vials) |
| 750mcg once daily | ~13 days | £3.00 | £21.00 | £168.00 (4.2 vials) |
At £40.00 per 10mg vial, Intex Pharma BPC-157 10mg is one of the most cost-effective verified peptides available in the UK. Use code WELCOME20 for 20% off your first order over £200 or INTEXBTC15 for 15% off with Bitcoin. Check verified customer reviews and verify the batch COA in the product gallery.
What to Expect: BPC-157 10mg Recovery Timeline
BPC-157 10mg: Typical Recovery Timeline for Tendon and Ligament Injuries
| Week | What Is Happening | What You May Notice |
|---|---|---|
| 1 | VEGF upregulation beginning; angiogenesis initiating at injection site; inflammatory modulation | Subtle at this stage. Some users report mild reduction in local inflammation or swelling |
| 2 to 3 | New blood vessel formation establishing improved blood supply to the injury; fibroblast activity increasing | Reduced pain during daily activities. Some users notice less stiffness in the morning or after periods of inactivity |
| 4 to 6 | Collagen deposition accelerating; tendon or ligament structural integrity improving; tissue remodelling underway | Meaningful improvement in pain during training. Lifts that were previously painful may become tolerable. Range of motion improving |
| 6 to 8 | Mature tissue repair progressing; structural strength of healing tissue increasing | Significant functional recovery for most moderate injuries. Training loads approaching pre-injury levels |
| 8+ | Continued remodelling; type III collagen transitioning to stronger type I collagen | Full or near-full functional recovery for many injuries. Chronic tendinopathies may require 12+ weeks |
These timelines are based on preclinical data and community-reported experience. Individual results vary based on injury severity, age, blood supply to the affected area, concurrent training load and whether the injury is being aggravated during the recovery period. Chronic tendinopathies that have been present for months or years typically require longer protocols (8 to 12 weeks) than acute injuries (4 to 6 weeks). Pairing BPC-157 10mg with Nandrolone Decanoate at a low dose creates a dual-pathway connective tissue support protocol as covered in the tendon recovery guide.
Available now at Intex Pharma UK
BPC-157 10mg: in stock, £40.00, same day despatch
Janoshik verified lyophilised peptide. 40 doses at 250mcg from a single vial. Use code WELCOME20 for 20% off your first order over £200.
BPC-157 10mg Dosing and Injection: Frequently Asked Questions
How much bacteriostatic water do I add to a BPC-157 10mg vial?
The most commonly recommended volume is 3ml, which produces a concentration of 3,333mcg/ml. At this concentration, 250mcg equals 7.5 units on a U-100 insulin syringe and 500mcg equals 15 units. Adding 2ml produces a more concentrated solution (5mg/ml) with smaller injection volumes but harder measurement. Adding 4ml produces a more dilute solution (2.5mg/ml) with easier measurement but slightly larger injection volumes. All three options deliver the same total amount of BPC-157 per vial.
Should I inject BPC-157 10mg near the injury or in my stomach?
For musculoskeletal injuries (tendon, ligament, muscle, joint), inject subcutaneously within 1 to 3cm of the injured structure. Research demonstrates enhanced healing velocity when BPC-157 is injected locally because the angiogenic signal is strongest at the point of highest concentration. For gut healing (IBS, oral steroid GI damage), either inject subcutaneously in the lower abdomen or take the dose orally dissolved in water on an empty stomach. BPC-157 is unusually acid-stable for a peptide, making oral administration effective for GI applications.
How long does a BPC-157 10mg vial last?
At 250mcg once daily, a BPC-157 10mg vial provides 40 doses (40 days, nearly six weeks). Dosing at 500mcg daily, one vial lasts 20 days. The common twice-daily protocol of 250mcg morning and evening provides 20 days of use from one vial. After reconstitution with bacteriostatic water, the solution should be used within 28 days.
How long does BPC-157 10mg take to work?
Most users report initial improvement in pain and inflammation within two to three weeks. Meaningful functional recovery for moderate tendon or ligament injuries typically occurs between weeks four and six. Chronic tendinopathies that have been present for months may require 8 to 12 weeks. The timeline depends on injury severity, age, blood supply to the area and whether the injury is being aggravated during recovery.
Can I inject BPC-157 10mg directly into a tendon?
No. Never inject directly into a tendon. Tendons have limited blood supply and poor tolerance for direct injection. Always inject into the subcutaneous tissue overlying the tendon, within 1 to 3cm of the injured structure. The BPC-157 will diffuse through the interstitial fluid to reach the tendon beneath. Use a 29 to 31 gauge insulin syringe at a 45-degree angle for subcutaneous injection.
Can I take BPC-157 10mg orally instead of injecting?
Yes, but oral administration is primarily effective for gut-related conditions (IBS, leaky gut, oral steroid GI damage, gastritis). BPC-157 is unusually stable in stomach acid for a peptide, which allows it to survive gastric transit and interact directly with the GI mucosa. For musculoskeletal injuries, subcutaneous injection near the injury site is significantly more effective than oral administration because it delivers the highest peptide concentration directly to the healing tissue.
How much does a BPC-157 10mg protocol cost with Intex Pharma?
At £40.00 per vial, a standard 8-week recovery protocol at 250mcg daily costs approximately £56.00 (1.4 vials). At 500mcg daily, the same protocol costs approximately £112.00 (2.8 vials). A preventative protocol at 250mcg daily across a 12-week steroid cycle uses approximately 2 vials at a total cost of £80.00.
Is Intex Pharma BPC-157 10mg third-party tested?
Yes. Every batch of Intex Pharma BPC-157 10mg is independently tested by Janoshik Analytical. The Certificate of Analysis confirming peptide identity, purity and concentration is published in the product gallery on the product page. Verify it at the Intex Pharma COA guide.